Pure Global
NCT05897606

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With Non-alcoholic Fatty Disease (NAFLD); RCR
Sulaimany Polytechnic university·Phase 1·ClinicalTrials.gov·combination productCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention
Multiviamins and minerals
Study type
Interventional
Intervention type
combination product
Sponsor & location
Primary sponsor
Sulaimany Polytechnic university
Location
Kurdistan, Iraq
Timeline & enrollment
Phase
Phase 1
Start date
Feb 01, 2023
End date
May 03, 2023
Enrollment
160 participants
Primary outcome

Multivitamin and minerals supplementation has role in reduce liver enzymes

Summary

The study was performed on 160 participants, to ensure the impact of multi vitamin and
 mineral to reduce NAFLD

ICD-10 classifications
Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05897606
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05897606 through Pure Global AI's free database. This Phase 1 trial is sponsored by Sulaimany Polytechnic university and is currently Completed. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 160 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.